Clinical Trials Directory

Trials / Sponsors / Corxel Pharmaceuticals

Corxel Pharmaceuticals

Industry · 11 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Type II Diabetes Mellitus
Phase 22026-02-06
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants
Obesity
Phase 22025-06-17
RecruitingOptimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Phase 2 / Phase 32025-05-15
CompletedSafety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese W
Presbyopia
Phase 12024-03-04
CompletedAn Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
Obstructive Hypertrophic Cardiomyopathy
Phase 32023-11-14
CompletedEvaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Presbyopia, Near Vision, Miosis
Phase 32023-09-27
CompletedA Study of Etripamil in Healthy Subjects
Healthy Chinese Subjects
Phase 12023-03-07
CompletedPharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease
Dry Eye Disease
Phase 12022-12-07
CompletedClinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of
Dry Eye Disease
Phase 32022-07-22
CompletedEfficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Epis
Tachycardia, Supraventricular, Paroxysmal Supraventricular Tachycardia
Phase 32022-06-30
CompletedSafety, Tolerability and Pharmacokinetics Study of CK-3773274
Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects
Phase 12021-04-10